National Taiwan University Hospital: Breast Neoplasms trials

The registry lists 40 Breast Neoplasms studies with National Taiwan University Hospital as lead sponsor. 13 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 13Phase 3 2Phase 4 2No phase 23(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Developing and Testing the Efficacy of AI-Chatbot-BasedNot yet recruitingNCT07791368Not applicable
• Effect of Preoperative Rehabilitation Exercise on Improving Postoperative Lymphedema, Quality of Life and Care Needs in Patients With Breast Cancer SurgeryRecruitingNCT07743294Not applicable
• Phase II Study of Ultrasound and ctDNA Guided Neoadjuvant Systemic Therapy for Patients With HER2-positive Early Breast Cancer (UC HER Trial)Not yet recruitingNCT07565324Phase 2
• Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast CancerRecruitingNCT06984250
• A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine GreenEnrolling by invitationNCT06768268Phase 1/2
• Rapid Histologic Assessment for Stereotactic Breast Biopsy: Enhancing Early Detection With Miniature Mass Spectrometry and AIRecruitingNCT06663228
• Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer PatientsRecruitingNCT06225284Phase 2
• A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBCRecruitingNCT05766410Phase 2
• LLLT for BCRL: a Randomized, Placebo-controlled StudyRecruitingNCT05725265Not applicable
• Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBCRecruitingNCT05720260Phase 2
• Microscopy Imaging of Whole-mount Stained Human TissuesRecruitingNCT05689112
• Olaparib Maintenance Therapy in Metastatic Breast CancerRecruitingNCT05629429Phase 2
• East Asian Breast Cancer Genome Atlas and Recurrence Risk PredictionRecruitingNCT04344496
• The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.CompletedNCT06370234Not applicable
• Managing Breast Cancer Treatment: Dyad's Perspectives on Treatment Decision, Financial and Family Burden.Status unknownNCT05917444
• Can ILR Reduce the Risk of Arm Lymphedema?Active, not recruitingNCT05742945Not applicable
• ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based TreatmentsStatus unknownNCT04212702
• Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 MutationStatus unknownNCT03544762Phase 3
• Ventilation Efficacy of Size 3 or Size 4 I-gel in Female Patient Weighing 50 to 60 KilogramsStatus unknownNCT03528590Not applicable
• 18F-FSPG PET/CT Imaging in Patients With CancersStatus unknownNCT03144622
• Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast CancerTerminatedNCT02990845Phase 1/2
• Integrated Positron Emission Tomography Magnetic Resonance (PET/MR) of Breast CancerStatus unknownNCT02766530Phase 4
• Edema Control in Patients With Breast Cancer-comparison of Manual Lymph Drainage and Epidermis Fascia TapingStatus unknownNCT02707835Not applicable
• Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of AfatinibStatus unknownNCT02511847Phase 2
• Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain MetastasesStatus unknownNCT02185352Phase 2
• A Continuing Cancer Service Model Emphasizing on Functional Restoration: Model for Breast CancerStatus unknownNCT01963572Not applicable
• Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer DiagnosisStatus unknownNCT01956409Phase 4
• 18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.Status unknownNCT01927939
• Effects on Physical Fitness, Immunity, and Quality of Life of Yoga Training in Breast Cancer Survivors.Status unknownNCT01743573Not applicable
• 18F-FLT PET for Suspicious Findings on Mammography and Breast UltrasoundStatus unknownNCT01713049Not applicable
• Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal MetastasisCompletedNCT01281696Phase 2
• Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast CancerCompletedNCT00912275Phase 1/2
• Effect of Combined Aerobic and Resisted Exercise in Breast Cancer SurvivorsCompletedNCT00877188Not applicable
• Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cmCompletedNCT00776724Phase 3
• The Diagnostic Efficacy of Computer-Aided Detection (CAD) in Full-Field Digital Mammography (FFDM)- A Prospective StudyStatus unknownNCT00173303
• The Study of Infrared Imaging on Breast CancerStatus unknownNCT00166998
• Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast CancerCompletedNCT00155259Phase 2
• Proton Magnetic Resonance Spectroscopy of Normal Breast Tissues in Women VolunteersStatus unknownNCT00155090
• Imaging Characteristics of Breast Cancer in Women Under 40 Years of AgeStatus unknownNCT00155038
• Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast CancerStatus unknownNCT00154882Phase 2